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Summary
Hyperpolarization-activated, cyclic-nucleotide-gated
(HCN) channels mediate the depolarizing cation
current (termed Ih or If) that initiates spontaneous
rhythmic activity in heart and brain. This function
critically depends on the reliable opening of HCN
channels in the subthreshold voltage-range. Here we
show that activation of HCN channels at physiologi-
cally relevant voltages requires interaction with
phosphoinositides such as phosphatidylinositol-4,5-
bisphosphate (PIP2). PIP2 acts as a ligand that
allosterically opens HCN channels by shifting voltage-
dependent channel activation w20 mV toward depo-
larized potentials. Allosteric gating by PIP2 occurs in
all HCN subtypes and is independent of the action of
cyclic nucleotides. In CNS neurons and cardiomyo-
cytes, enzymatic degradation of phospholipids results
in reduced channel activation and slowing of the spon-
taneous firing rate. These results demonstrate that
gating by phospholipids is essential for the pacemak-
ing activity of HCN channels in cardiac and neuronal
rhythmogenesis.
Introduction
Hyperpolarization-activated, cyclic-nucleotide-gated
(HCN) ion channels are widely expressed in the mamma-
lian heart and brain, where they give rise to the slowly
activating cationic current known as Ih, Iq, or If (Brown
et al., 1979; Halliwell and Adams, 1982). Molecularly,
mammalian HCN channels are assembled as homo- or
heterotetramers from protein subunits encoded by the
four different genes HCN1-4 (Ludwig et al., 1998;
*Correspondence: roeper@mailer.uni-marburg.de (J.R.), bernd.
fakler@physiologie.uni-freiburg.de (B.F.)Santoro et al., 1998). Upon heterologous expression,
all HCN isoforms reproduce the functional hallmarks of
their native counterparts (for review see Baruscotti
et al., 2005; Kaupp and Seifert, 2001; Robinson and Sie-
gelbaum, 2003). They open in response to membrane
hyperpolarization and close upon depolarization, their
activation and deactivation kinetics are slow (time
constants in the range of hundreds of milliseconds to
seconds), they are permeable to both Na+ and K+ ions,
and their voltage-dependent gating is modulated by
cAMP. Binding of cAMP to a C-terminal cyclic-nucleo-
tide-binding domain (CNBD) shifts voltage-dependent
activation of HCN channels to more depolarized poten-
tials, thereby enhancing channel opening (DiFrancesco
and Tortora, 1991; Wainger et al., 2001).
In the cellular context, HCN channels were found to be
responsible for a variety of physiological functions as-
cribed to Ih. These are control of pacemaker activity in
both heart and brain (DiFrancesco, 1993; Pape and
McCormick, 1989), determination of the resting mem-
brane potential (Williams and Stuart, 2000), and control
of membrane resistance and synaptic integration in den-
drites (Magee, 1999) as well as primary sensory trans-
duction (Stevens et al., 2001).
A prerequisite for any of these functions is reliable ac-
tivity of HCN channels in the subthreshold voltage range
(usually between 250 mV and 280 mV), which requires
‘‘appropriate localization’’ of the channels’ steady-state
activation curve on the voltage axis (Frere et al., 2004).
This localization is dynamic, and the intracellular level
of cAMP is thought to be the key mechanism for the
dynamic control of voltage-dependent gating of HCN
channels (DiFrancesco and Tortora, 1991). There is,
however, strong experimental evidence for an additional
regulatory factor that is independent of cyclic nucleo-
tides and appears to be effective in all HCN subtypes
(Chen et al., 2001; DiFrancesco et al., 1986; DiFrancesco
and Mangoni, 1994). Thus, currents through native and
heterologously expressed HCN channels display pro-
nounced ‘‘run-down’’ in excised patches or during
prolonged whole-cell recordings that results from an ex-
tensive 30–50 mV hyperpolarizing shift of the steady-
state activation (Chen et al., 2001; DiFrancesco et al.,
1986). Effects on the basal level of cAMP may only ac-
count for up to 15–20 mV of this shift (Chen et al.,
2001). In addition, the potential required for half-maxi-
mal activation (V1/2) of native HCN channels exhibits
considerable variation among cell types (for review see
Baruscotti et al., 2005; Santoro and Tibbs, 1999), or,
quite explicitly in the heart, among cells of distinct re-
gional distribution or at different developmental stages
(Boyett et al., 2000; Cerbai et al., 1999; Robinson et al.,
1997). Most strikingly, a 20 mV difference in V1/2 was re-
ported between HCN2 channels overexpressed (by viral
transfection) in newborn and adult ventricular myocytes
at saturating cAMP (Qu et al., 2001).
The molecular factor behind this ‘‘context depen-
dence’’ (Baruscotti et al., 2005) as well as behind the
run-down of HCN channels in excised patches and
whole-cell recordings has remained elusive.
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gously expressed HCN channels may be controlled by
membrane phospholipids such as PIP2. These phos-
phoinositides operate as allosteric ligands that shift
the voltage-dependent activation of HCN channels to-
ward depolarized potentials and thus enable robust
channel activation in the voltage range relevant for the
physiological role of Ih channels.
Results
Gating of HCN Channels in Dopaminergic Midbrain
Neurons Is Altered by Wortmannin
HCN channels in adult dopaminergic (DA) midbrain neu-
rons of the substantia nigra (SN; Neuhoff et al., 2002)
were investigated with the perforated-patch technique
in voltage- and current-clamp configuration under con-
trol conditions and after a 30 min preincubation of the
brain slices with wortmannin (10 mM), an inhibitor of
the type-III PI 4-kinase at micromolar concentrations
(Vanhaesebroeck et al., 2001; Balla and Balla, 2006).
As illustrated in Figures 1A and 1B (left panel), HCN
channels of DA SN neurons were activated under either
condition upon hyperpolarizing voltage steps. However,
HCN channels in neurons pretreated with wortmannin
required more hyperpolarizing voltage commands for
equivalent activation compared to channels recorded
under control conditions. When quantified in steady-
state activation curves (see Experimental Procedures),
wortmannin treatment led to a left-shift of channel acti-
vation by >10 mV, with voltages for half-maximal activa-
tion (V1/2) of 265.4 mV and 277.6 mV determined with
Boltzmann fits to the mean steady-state activation of
control and wortmannin-treated HCN channels, respec-
tively (Figure 1C). The steepness of the activation curve
(slope factor) reflecting the voltage dependence of
channel activation was not affected by the PI-kinase in-
hibitor (Figure 1C; values of 7.9 mV and 7.8 mV for wort-
mannin-treated neurons and controls, respectively). In
line with the left-shifted activation of HCN channels,
the voltage response of wortmannin-treated DA SN neu-
rons to injection of hyperpolarizing current (250 pA,
275 pA) was markedly different from controls. Thus,
the prominent voltage-sag reflecting activation of HCN
channels was markedly diminished and slowed in wort-
mannin-treated cells, the rebound delay was prolonged,
and the following spiking activity was reduced (Figures
1A and 1B, right panel).
The wortmannin-induced modulation of HCN gating
was further investigated in perforated-patch current-
clamp recordings monitoring the spontaneous firing of
DA SN neurons. As illustrated in Figures 2A and 2B,
a 20 min application of wortmannin led to a marked de-
crease of the spiking frequency in all neurons tested,
which was not reversed by 8-bromo-cAMP (8-Br-
cAMP; 100 mM) added to the bath solution in a con-
centration saturating for activation of HCN channels
(Figures 2A and 2B). Moreover, no significant effect of
wortmannin was observed when HCN channels were
blocked by the HCN channel blocker ZD7288 (10 mM;
Figure S2 in the Supplemental Data available online).
Comparison of interspike intervals obtained under
control conditions and those recorded during applica-
tion of wortmannin or ZD7288 (30 mM) showed that wort-mannin decreased the slope of the ‘‘pacemaker’’ depo-
larization without changing the threshold of firing
(Figure 2C).
Together, these results indicated that the voltage-
dependent gating of HCN channels is modulated by
the PI 4-kinase inhibitor wortmannin and that this mod-
ulation is independent of cyclic nucleotides.
‘‘Wash-Out’’ Effect on HCN Gating Is Reversed
by Membrane Phospholipids
Cyclic-nucleotide-independentmodulationofHCNchan-
nel gating was further observed with HCN2 mutant
Figure 1. Modulation of HCN Gating in Dopaminergic Midbrain Neu-
rons by Wortmannin
(A and B) (Left panels) Amphotericin perforated-patch whole-cell
voltage-clamp recordings of HCN currents elicited by voltage steps
of increasing amplitude (to potentials between 250 mV and
2110 mV) and decreasing duration (from 8.5 s to 5.5 s) from a holding
potential of240 mV, followed by a 500 ms voltage step to2120 mV.
Traces in red are current responses to voltage steps to 280 mV.
(Right panels) Perforated-patch whole-cell current-clamp record-
ings of the membrane potential in response to 2 s current injections
of 250 pA and 275 pA. Traces in red are voltage responses to
275 pA current injections. Note the reduced and slowed HCN-
induced voltage sag and the prolonged spike delay after wortman-
nin treatment compared to control (sag amplitudes of wortmannin-
treated cells and controls were 3.6 mV and 8.4 mV [for the 250 pA
current injection] and 10.7 mV and 14.8 mV [for the 275 pA current
injection], respectively).
(C) Steady-state activation curves of HCN channels in DA SN neu-
rons recorded in the perforated-patch configuration in controls
and after wortmannin treatment. Data points are mean 6 SEM of
seven experiments; continuous lines are fit of a Boltzmann function
to the data with values for V1/2 and slope factor of 265.4 mV and
7.8 mV (controls) and 277.6 mV and 7.9 mV (wortmannin), respec-
tively. Note the shift to negative membrane potentials induced by
wortmannin treatment.
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et al., 2001) and HCN2(DCNBD) (Wainger et al., 2001)].
Following patch excision from Xenopus oocytes, cur-
rents mediated by HCN2(R591E) channels and activated
by a hyperpolarizing voltage step to 2120 mV succes-
sively decreased in amplitude (to w20% of the cell-at-
tached value), while their rising phase was successively
slowed (w3-fold increase in activation time constant;
Figure 3A, inset). The changes in both amplitude and
activation time course resulted from a shift of the acti-
vation curve to more hyperpolarized potentials, which,
after a 5 min perfusion of the inside-out (i-o) patches, ex-
hibited values ofw20 mV (V1/2 of2120.3 mV; Figure 3B).
Similarly, the steady-state activation curve of HCN2
wild-type channels was largely shifted to the left upon
perfusion of i-o patches. As shown in Figure 3B, the
respective shift at steady-state wash-out was w40 mV
(V1/2 of 2120.1 mV; Figure 3B), with half of this value
Figure 2. Effect of Wortmannin-Mediated Modulation of HCN on the
Spontaneous Firing in Dopaminergic Midbrain Neurons
(A) Gramicidin perforated-patch whole-cell current-clamp record-
ings of spontaneous firing of a DA SN neuron under control condi-
tions and after bath application of 10 mM wortmannin and 100 mM
8-Br-cAMP. Note that the wortmannin-induced reduction of the
firing rate is not altered by the additional application of 8-Br-cAMP.
(B) Mean firing rates of four spontaneously active DA SN neurons
under control conditions and after application of wortmannin and
8-Br-cAMP (reduction of firing rate is significant with a p value of
0.01, paired Student’s t test). (Inset) Spontaneous firing rates of
another four DA SN neurons before and after application of 8-Br-
cAMP (firing rates were not significantly different, p > 0.05, paired
Student’s t test).
(C) Interspike intervals of spontaneously active DA SN neurons un-
der control conditions and after wortmannin application or after
complete inhibition of HCN currents by 30 mM ZD7288.(DV1/2 of 19.2 6 2.3 mV, n = 6) being due to the wash-
out of cAMP. The remaining cAMP-independent shift
in HCN2 wt as well as the shift observed with the cAMP-
insensitive mutant HCN2(R591E) has been attributed to a
yet unknown modulatory mechanism (Baruscotti et al.,
2005; Santoro and Tibbs, 1999).
Prompted by the gating effect of wortmannin on na-
tive HCN channels and the known enzymatic degrada-
tion of phospholipids in perfused i-o patches (Baukro-
witz et al., 1998; Huang et al., 1998; Oliver et al., 2004),
phosphatidylinositol-4,5-bisphosphate (PIP2) under sat-
urating conditions (Figure S1) was probed for its effect
on HCN2 channels. As illustrated in Figure 4, the phos-
pholipid added as suspension (see Experimental
Procedures) induced an w20 mV shift of the activation
Figure 3. Shift in Voltage-Dependent Gating of HCN Channels by
Perfusion of Excised i-o Patches
(A) Currents mediated by cAMP-insensitive HCN2(R591E) channels
decrease in amplitude following patch excision. Currents were mea-
sured in response to successive 2.5 s voltage steps to 2120 mV
(from a holding potential of 0 mV, tail potential 50 mV) and normal-
ized to the cell-attached amplitude. (Inset) Current traces recorded
at the indicated time points; values for tactivation were 1.25 s (black
trace), 3.38 s (red trace). Current scale is 1 nA, timescale as indi-
cated, horizontal line is zero current.
(B) Steady-state activation curves of HCN2 wt and HCN2(R591E)
mutant channels determined in whole oocytes and inside-out
patches after a 5 min perfusion. Data points are mean (6SEM) of
ten (patches) and seven (whole-cell) experiments, respectively.
Lines are fit of a Boltzmann function to the data with values for
V1/2 and slope factor of 279.8 mV and 8.1 mV (HCN2 wt, whole
cell) and 2120.1 mV and 6.5 mV (HCN2 wt, i-o patch), 299.4 mV
and 9.2 mV [HCN2(R591E), whole cell], and 2120.3 mV and 5.1 mV
[HCN2(R591E), i-o patch].
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HCN2(R591E) (DV1/2 of 20.1 6 3.2 mV, n = 4) or
HCN2(DCNBD) (DV1/2 of 19.161.5 mV, n = 4) channels af-
ter steady-state wash-out. Viewed as response to a volt-
age step to2110 mV, this right-shift in channel activation
translated into currents with markedly increased ampli-
tude and accelerated rising phase (Figure 4A, inset).
Very similar results were obtained with PIP2 applied to
extensively perfused HCN2 wild-type channels. Thus,
the steady-state activation curve was shifted to the right
by 18.0 6 0.8 mV (DV1/2; n = 10) at constant slope factor
Figure 4. Reverse Shift in Voltage-Dependent Gating of HCN Chan-
nels by PIP2
(A) Steady-state activation curves of HCN2(R591E) mutant channels
determined before (washed) and after a 5 s application of PIP2
(10 mM; red) and during subsequent application of cAMP (100 mM;
gray). Data points are mean (6SEM) of four patches. Lines are fit
of a Boltzmann function to the data with values for V1/2 and slope
factor of 2122.0 mV and 4.6 mV (washed), 2102.1 mV and 4.9 mV
(PIP2), 2100.8 mV and 4.9 mV (+cAMP). (Inset) Representative cur-
rent traces recorded in response to a step potential of 2110 mV
(from a holding potential of 0 mV, tail potential 50 mV), values for
tactivation were 1.91 s (washed), 0.95 s (PIP2), and 0.86 s (+cAMP).
Current scale is 1 nA, timescale as indicated, horizontal line is zero
current.
(B) Steady-state activation curves as in (A) for HCN2(DCNBD) mutant
channels. Data points are mean (6SEM) of four patches. Lines are fit
of a Boltzmann function to the data with values for V1/2 and slope
factor of 2103.4 mV and 7.4 mV (washed), 285.7 mV and 5.8 mV
(PIP2), 284.9 mV and 6.3 mV (+cAMP). and the time course of channel activation (at a given test
potential) was accelerated over the entire voltage range
tested (Figure 5A). The channel conductance remained
unaffected (mean 6 SD of the rel. conductance after
PIP2 application was 0.99 6 0.12 of that obtained after
steady-state wash-out, n = 8). Different from the
HCN2(R591E) and HCN2(DCNBD) mutants, activation
of wild-type channels was further shifted to the right
by 19.16 2.1 mV (DV1/2; n = 10) upon subsequent appli-
cation of 100 mM cAMP (Figure 5A). The resulting activa-
tion curve exhibited a V1/2 of 283.1 6 3.2 mV (n = 10),
closely matching the value determined in voltage-clamp
recordings from whole oocytes (V1/2 = 280.1 6 2.1 mV,
n = 7; Figure 3B). The V1/2 shifts obtained with both
Figure 5. PIP2-Mediated Shift in HCN Gating Is Not Affected by
cAMP
(A) Steady-state activation curves of HCN2 channels determined
before (washed) and after a 5 s application of PIP2 (10 mM; red)
and during subsequent application of cAMP (100 mM; gray). Data
points are mean (6SEM) of ten patches. Lines are fit of a Boltzmann
function to the data with values for V1/2 and slope factor of
2120.1 mV and 6.4 mV (washed), 2102.1 mV and 6.4 mV (PIP2),
and283.1 mV and 5.9 mV (+cAMP after PIP2). (Inset) Representative
current traces recorded in response to voltage steps to potentials
between 250 mV and 2140 mV (washed), 2120 mV (PIP2) or
2110 mV (+cAMP after PIP2) in 10 mV increments (holding potential
was 0 mV, tail potential 50 mV). Traces in red are responses to a step
potential of 2110 mV; current scale is 1 nA, timescale as indicated.
(B) Steady-state activation curves as in (A) determined before
(washed) and during application of cAMP prior to (100 mM; gray)
and after a 5 s application of PIP2 (10 mM; red). Data points are
mean (6SEM) of six patches. Lines are fit of a Boltzmann function
to the data with values for V1/2 and slope factor of 2118.4 mV and
6.3 mV (washed), 299.1 mV and 5.9 mV (cAMP), and 278.6 mV
and 6.9 mV (cAMP+PIP2).
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(A) Current recordings in response to the indicated voltage protocol and the application of PIP2 (10 mM; upper panel) or cAMP (100 mM; lower
panel); current and time scaling as indicated. Note that activation by either ligand equalled that of a 20 mV hyperpolarization.
(B) Summary of the shift in activation curve induced by PIP2 and cAMP in the HCN channel subtypes indicated. Data are mean (6SD) of ten
(HCN1, HCN2) and four (HCN4) patches, respectively.
(C) Shift in voltage-dependent activation of HCN2 by PIP2 (10 mM, 5 s) was removed by polyK (25 mg/ml). Subsequent application of heparin
(100 mg/ml) restored the effect of PIP2. Currents were recorded in response to 2.5 s voltage steps from 0 mV to 2105 mV followed by 0.5 s
step to 50 mV. (Insets) Traces recorded at the time points indicated by arrows. Traces recorded after PIP2 and with heparin are in black; traces
recorded prior to PIP2 and after polyK are in gray.
(D) Summary of the effects of PIP2, polyK, and heparin; data are mean 6 SD of six patches.
(E) Phosphatidylinositol-4-phosphate (PIP), PIP2, and phosphatidylinositol-3,4,5-triphosphate (PIP3) (10 mM, 5 s; each) shifted voltage-depen-
dent activation of HCN2 channels, whereas PI (20 mM, 5 s) failed. Data are mean6 SD of five (PI), four (PIP), ten (PIP2) and six (PIP3) experiments.PIP2 and saturating cAMP were independent of the
order of application (Figure 5B), with DV1/2 values of
18.4 6 2.6 mV (PIP2 in the presence of cAMP; n = 6)
and 19.26 2.3 mV (cAMP prior to PIP2; n = 6). In addition,
the affinity of HCN2 channels for cAMP was not affected
by the phospholipid (data not shown).
Together, these results indicated that PIP2 determines
the voltage range of HCN2 channel gating independently
of cyclic nucleotides and that the combined effects of
PIP2 and cAMP were able to restore channel activation
in excised patches to its appearance in intact cells.
Activation of HCN Channels by Membrane
Phospholipids
The observed 20 mV shift in steady-state activation im-
plies that PIP2 and cAMP should induce robust opening
of HCN2 channels when applied at appropriately nega-
tive membrane potentials. This was tested in experi-
ments that used motor-driven fast application of either
activating molecule to washed-out HCN2 channels at
a constant membrane potential. As shown in Figure 6A,
PIP2 and cAMP effectively activated HCN2 channels at
a test potential of2100 mV, where no or very little chan-
nel activity was observed prior to application. The acti-
vating potency of both molecules was similar and
equalled that of a 20 mV hyperpolarization, as reflectedby the current response to a voltage step from2100 mV
to2120 mV preceeding the application of PIP2 or cAMP
(Figure 6A).
Thus, both PIP2 and cAMP may be regarded as li-
gands that allosterically activate HCN2 channels, sup-
posedly though by distinct mechanisms. This was fur-
ther investigated by probing both ligands for effects on
other HCN subtypes as well as by further characterizing
the mode of action of the PIP2 molecule. As illustrated in
Figure 6B, the activation properties of PIP2 and cAMP
were distinct among HCN subtypes. Thus, in HCN4,
both molecules shifted the activation curve by >15 mV,
while in HCN1 channels the V1/2 shift induced by the
phospholipid largely exceeded that of the cyclic nucleo-
tide (Figure 6B). Moreover, channel activation by cAMP
required its continuous presence and was rapidly re-
versed upon wash-out (Figure 6A), while channel activa-
tion by PIP2 occurred after brief application (Figure 6A)
and persisted despite extensive perfusion with PIP2-
free solution for as long as the excised patches
remained stable. The effect of PIP2, however, was abol-
ished by poly-lysine (polyK, 25 mg/ml), a poly-cation that
tightly binds to the negatively charged head moiety of
PIP2, and it was almost fully restored upon subsequent
application of heparin, a poly-anion known to remove
polyK from patches (Oliver et al., 2004; Figures 6C and
Neuron
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sensitivity to charge-shielding suggested that phos-
phoinositide-mediated activation of HCN channels
requires insertion of the phospholipid into the plasma
membrane and a negative moiety at its headgroup, sim-
ilar to what is known for PIP2-mediated gating modula-
tion of Kir and Kv channels (Huang et al., 1998; Oliver
et al., 2004; Rohacs et al., 2003; Shyng and Nichols,
1998). The contribution of the negatively charged head-
groups was further investigated using phosphoinositi-
des with a variable number of phosphate groups at the
inositol ring. As summarized in Figure 6E, all phospho-
lipids bearing a negatively charged headgroup were
about equally effective, while phosphatidylinositol (PI)
with its fully dephosphorylated inositol ring failed to shift
the activation curve of HCN channels.
Together, these results indicated that both PIP2 and
cAMP operate as ligands that allosterically activate
HCN channels and that channel activation by PIP2
is mediated by membrane-inserted phosphoinositides
through electrostatic interactions.
Alteration of HCN Gating by Enzymatic Modulation
of Phospholipids
Next, the modulation of HCN channel gating induced by
interference with enzymatic activities required for main-
tenance of phospholipids was probed in Xenopus
oocytes and cultured cells. First, the membrane-associ-
ated lipid phosphatases of oocytes that are known to be
very active in excised patches (Huang et al., 1998) were
inhibited by addition of fluoride (5 mM), vanadate
(0.1 mM), and pyrophosphate (10 mM) to the perfusion
solution (FVPP solution, see Experimental Procedures).
As shown in Figure 7A, this largely slowed the decay of
HCN2-mediated currents (n = 6) observed under control
conditions (cAMP-containing intracellular solution).
When approximated with monoexponentials, the re-
spective time constants for the current decay (mean 6
SD) were 35.0 6 15.8 s (n = 6) in control conditions and
286.4 6 105.2 s (n = 5) after addition of FVPP.
A second set of experiments decreased the amount of
PIP2 in the plasma membrane either by inhibition of the
PI 4-kinase (wortmannin, 10 mM) or by coexpression of
the membrane-targeted inositol 5-phosphatase domain
of synaptojanin 1, a highly active PIP2 phosphatase
(Milosevic et al., 2005). Thus, the steady-state activation
curve of HCN2 channels expressed in CHO cells and re-
corded in whole-cell configuration was left-shifted by
w10 mV (Figure 7B, left panel) after wortmannin-treat-
ment, similar to the observation on native HCN channels
in DA SN neurons (Figure 1A). The slope factor of the
activation curve was not affected by wortmannin
(Figure 7B, left panel). Similar results for wortmannin-
induced changes in the activation curve were obtained
with HCN1 channels expressed in CHO cells (DV1/2
induced by wortmannin treatment was 9.1 mV; data
not shown). Coexpression of synaptojanin in Xenopus
oocytes resulted in an w10 mV left-shift of the steady-
state activation curve of HCN2 channels at constant
slope factor (Figure 7B, right panel).
These results confirm the effects obtained with PIP2
application onto excised patches and suggest that
phosphoinositides may be regulators of HCN channel
gating under cellular conditions.Phospholipid Regulation of HCN Gating
in Cardiomyocytes
Regulation by phosphoinositides may be expected to be
a general property of HCN channels and should, there-
fore, be cell-type and tissue independent. This was
tested by probing HCN channels in cardiomyocytes for
their sensitivity to modulation in membrane phospho-
lipids. Figure 8A illustrates HCN-mediated currents
recorded in an early embryonic (E9.5) cardiomyocyte
in response to hyperpolarizing voltage steps immedi-
ately after establishing whole-cell configuration and
after a 10 min application of wortmannin (10 mM). Similar
Figure 7. Modulation of HCN Gating by Enzymatic Alteration of
Membrane Phosphoinositides
(A) Addition of FVPP to the internal solution slows the decrease of
HCN2-mediated currents induced by patch excision from Xenopus
oocytes. Data points are maximal currents (normalized to the ampli-
tude recorded in cell-attached configuration right before patch exci-
sion) recorded in response to successive 2.5 s voltage steps to
2100 mV in the absence (open gray) or presence of FVPP (filled
black) in the cAMP (100 mM) containing perfusion solution. (Insets)
Current traces recorded at the time points indicated by arrows; scale
bars are 1 nA and 0.5 s.
(B) (Left panel) Steady-state activation curves of HCN2 channels ex-
pressed in CHO cells under control conditions (open black) or after
preincubation with wortmannin (10 mM, 30 min; filled red). Data
points are mean 6 SEM of seven cells. Lines are fit of a Boltzmann
function to the data with values for V1/2 and slope factor of 279.9
mV and 6.3 mV (control), 289.0 mV and 6.7 mV (wortmannin). (Right
panel) Steady-state activation curves of HCN2 channels expressed
alone (open black) or together with the PIP2 phosphatase synapto-
janin (filled red) in Xenopus oocytes. Activation curves were deter-
mined in recordings from whole oocytes; data points are mean 6
SEM of six (coexpression of synaptojanin) and eight (control)
oocytes. Lines are fit of a Boltzmann function to the data with values
for V1/2 and slope factor of281.0 mV and 9.5 mV (control),290.5 mV
and 7.9 mV (synaptojanin).
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erologous systems, steady-state activation curves of
cardiac HCN channels were shifted w10 mV to the left
by wortmannin treatment (Figures 8B and 8C); this shift
was independent of cyclic nucleotides, as saturating
levels of intracellular cAMP were maintained by addition
of 8-bromo-cAMP (100 mM) to the bath solution (control).
In contrast to the perforated-patch recordings from DA
SN neurons (Figures 1 and 2), wash-out of the cardio-
myocytes via the whole-cell pipette resulted in left-shift
of the activation curve with a DV1/2 of 5.2 6 1.2 mV
(mean 6 SEM of 7 cells). This wash-out was prevented
by addition of PIP2 (20 mM) to the pipette solution
(Figure 8C).
Discussion
The central finding of this work is that activation of HCN
channels in the physiological voltage range and hence
its classical role in rhythmogenesis requires interaction
with phosphoinositides such as PIP2. These phospho-
lipids produce a right-shift of the steady-state activation
by w20 mV and, together with cAMP, restore channel
Figure 8. Phosphoinositide-Dependent Gating of HCN Channels in
Embryonic Cardiomyocytes
(A) HCN-mediated currents recorded under control conditions (left
panel; 100 mM 8-Br-cAMP in the bath solution) and after a 10 min
application of wortmannin (10 mM, 100 mM 8-Br-cAMP in the bath
solution) in response to 2.5 s voltage-steps to potentials between
240 mV and 2110 mV (10 mV increment, holding potential
240 mV) followed by a voltage step to 2110 mV. Red traces are
responses to a step potential of 280 mV; current scaling is 0.1 nA,
time scaling as indicated.
(B) Steady-state activation curves obtained from representative ex-
periments as in (A). Lines are fit of a Boltzmann function to the data
with values for V1/2 and slope factor of 274.4 mV and 9.7 mV (con-
trol), 284.9 mV and 7.9 mV (wortmannin).
(C) Summary of V1/2 shifts obtained under the experimental condi-
tions indicated. Data are mean 6 SEM of seven (control), four
(PIP2), and seven (wortmannin) cardiomyocytes. PIP2 (20 mM) was
added to the whole-cell pipette, wortmannin (10 mM) was added to
the bath solution; all solutions contained 8-Br-cAMP (100 mM).activation in excised patches to their appearance in
intact cells. The results establish PIP2 as a novel and
independent modulator of HCN channel gating and
suggest that phosphoinositides may be the missing
regulatory factor of Ih physiology.
Characteristics of HCN Channel Gating
by Phosphoinositides
This latter suggestion arises from coincidence of the
characteristics described here for PIP2-mediated gating
modulation and the hallmarks of the unknown regulatory
factor thought to be responsible for ‘‘context depen-
dence’’ or ‘‘run-down’’ of HCN-mediated currents (Bar-
uscotti et al., 2005; Robinson and Siegelbaum, 2003).
First, enzymatic degradation of phosphoinositides
changes activation of HCN gating in all cell types inves-
tigated (Figures 1, 7, and 8), and application of exoge-
nous PIP2 reversed the channel run-down induced by
extensive wash-out (Figures 3–5 and Pian et al., 2006).
Second, phosphoinositide modulation of HCN gating is
different from and independent of cyclic nucleotides.
This is emphasized by the identical effectiveness of
PIP2 in both HCN2 wild-type (Figure 5) and the cAMP-
insensitive mutants R591E and DCNBD (Figure 4), as
well as by the observation that the PIP2-induced shift
in activation was independent of whether the phos-
pholipid was applied before or together with saturating
concentrations of cAMP (Figure 5). Independence of
phosphoinositide and cyclic-nucleotide gating, how-
ever, was only observed here with the physiologically
occurring long-chain fatty acid PIP2, while water-soluble
dioctanoylphosphoinositides (short-chain fatty acids)
appear to be affected by cAMP (Pian et al., 2006). Third,
PIP2 proved to be equally effective in all HCN subtypes
tested (HCN1, 2, 4; Figure 6B) similar to what was previ-
ously suggested for the unknown regulatory factor in
native and heterologously expressed HCN channels
(Chen et al., 2001).
Mechanistically, activation of HCN channels is medi-
ated by phosphoinositides inserted into the plasma
membrane (Figure 6C) and occurs through electrostatic
interactions between their negatively charged head-
group and the channel protein (Figures 6C–6E), similar
to PIP modulation of gating in Kv (Oliver et al., 2004)
and Kir channels (Baukrowitz et al., 1998; Huang et al.,
1998; Shyng and Nichols, 1998). As a consequence of
the lipid-protein interaction, voltage-dependent activa-
tion of HCN channels is facilitated, or, at appropriately
negative membrane potentials, opening of the channel
pore is initiated (Figure 6A). The PIP2 action thus closely
resembles that of cyclic nucleotides, which also trigger
channel opening in a ligand-like manner (Figure 6A), al-
though most likely by acting through different domain(s)
of the HCN protein, as evidenced by the dissociation of
both the cAMP and PIP2 effect in HCN1 (Figure 6). In
HCN1 channels, the cAMP-mediated shift in V1/2 is
largely reduced with respect to HCNs 2 and 4, in con-
trast to the phosphoinositide-mediated DV1/2 that is
similar in all HCN subtypes.
Taking these characteristics into account and analo-
gous to the mechanism underlying activation of HCN
channels by cAMP (Ulens and Siegelbaum, 2003;
Wainger et al., 2001; Zagotta et al., 2003), the phosphoi-
nositide effect may result from relieving inhibition of
Neuron
1034channel opening imposed by a protein domain different
from the CNBD (Ulens and Siegelbaum, 2003; Wainger
et al., 2001). Both, the inhibitory actions by the CNBD
and by the ‘‘PIP domain’’ operate independent of each
other and combine to shift the HCN2 activation curve
to the left by w40 mV when both ligands are absent.
Vice versa, binding of PIP2 and cAMP to their respective
sites may cause maximal disinhibition and thus allow for
efficient channel activity in the physiological subthresh-
old voltage range (Figures 4–6). Alternative to action via
different domains, phosphoinositides and cyclic nucleo-
tides may act through linked domains with a ‘‘coupling
efficiency’’ beyond our detection threshold. However,
both the PIP2 interaction site on the channel protein as
well as the proposed mechanism of action still awaits
verification and further determination.
Physiological Significance of Gating Regulation
by Phospholipids
The physiological functions of HCN channels, in particu-
lar their control of pacemaking in heart and brain, criti-
cally depend on reliable opening of the channels in a
narrow subthreshold voltage window (Baruscotti et al.,
2005; Frere et al., 2004; Robinson and Siegelbaum,
2003). Consequently, a 20 mV shift of the activation
curve, as observed after depletion of PIP2 from the
plasma membrane (Figure 5), should profoundly impact
on the Ih physiology, as shown here for the spontaneous
spiking of DA SN neurons. Depletion of PIP2 (by wort-
mannin-mediated inhibition of the PI 4-kinase) not only
shifted steady-state activation of the HCN channels by
w10 mV (Figures 1 and 2) but also slowed down the
frequency of spontaneous firing in all neurons tested
(Figure 2).
Profound cAMP-independent variations in the mid-
point of voltage-dependent activation are well-docu-
mented for HCN channels expressed in cardiac cells of
different developmental stage or distinct regional distri-
bution (Cerbai et al., 1999; Qu et al., 2001; Robinson
et al., 1997). Based on the observed PIP2 effects on re-
combinant and native HCN channels in cardiomyocytes
(Figures 5 and 8), it might be interesting to investigate
the developmental and localization-dependent proper-
ties for potential involvement of phosphoinositides.
Experimental Procedures
Recordings from Adult Dopaminergic Neurons in Brain Slices
250 mm coronal midbrain slices of 3-month-old male C57Bl6/J mice
were sectioned after intracardial perfusion with ice-cold sucrose-
ACSF (in mM): 50 sucrose, 75 NaCl, 25 NaHCO3, 2.5 KCl,
1.25 NaH2PO4, 0.1 CaCl2, 6 MgCl2, and 2.5 glucose, oxygenated
with 95% O2, 5% CO2). After 90 min of recovery, slices were trans-
ferred to a recording chamber and perfused continuously at 2–4
ml/min with oxygenated ACSF (2.5 mM glucose, 22.5 mM sucrose)
at 36C. Fast excitatory and inhibitory synaptic transmission was
inhibited by 20 mM CNQX and 10 mM gabazine. Dopaminergic (DA)
midbrain neurons in the substantia nigra (SN) were identified using
accepted anatomical landmarks (SN lateral of lemniscus medialis)
in combination with their typical electrophysiological properties,
like spontaneous pacemaker activities and broad action potentials.
Perforated-patch recordings, data acquisition, and analysis were as
previously described (Neuhoff et al., 2002). For voltage-clamp re-
cordings, amphotericin (50 mg/ml DMSO stock, final 50 mg/ml in
pipette solution) was used for pore formation, resulting in low series
resistances (Rs < 20 MOhm, Rs compensation at 75%, voltage
errors < 5 mV). For stable long-term current-clamp recordingsof spontaneous activity, gramicidin (50 mg/ml DMSO stock,
100 mg/ml final in pipette solution) was used for pore formation.
Steady-state activation curves were determined with a tail-current
protocol. Briefly, preconditioning voltage steps (from a holding po-
tential of 240 mV) were applied to potentials between 0 mV and
2120 mV for durations ranging between 9 s and 5 s, before the mem-
brane potential was stepped to2120 mV for 500 ms to elicit HCN tail
currents. Tail currents were normalized to maximum, plotted against
the preconditioning potential, and fitted with a Boltzmann function:
I(norm) = 1/(1 + exp((V 2 V1/2)/k)). V1/2 is voltage required for half-
maximal activation; k is the slope factor.
Electrophysiology and Data Analysis of Cloned HCN Channels
Preparation and injection of cRNA into Xenopus oocytes and site-
directed mutagenesis were done as described (Fakler et al., 1995);
cell culturing and transfection of cDNAs were performed as detailed
in Ludwig et al. (2001). All cDNAs were verified by sequencing;
GeneBank accessions of the clones used were AJ225123.1
(HCN1), AJ225122.1 (HCN2), AJ132429.1 (HCN4). The membrane-
targeted 5-inositol phosphatase domain of synaptojanin 1 was a
gift of Dr. V. Haucke (Krauss et al., 2003; Milosevic et al., 2005).
Electrophysiological recordings from giant inside-out patches
excised from oocytes were performed at room temperature (22C–
24C) as described previously (Fakler et al., 1995). Briefly, currents
were recorded with an EPC9 amplifier, low-pass filtered at 1 kHz,
and sampled at 2 kHz; capacitive transients were compensated
with the automated circuit of the EPC9. Pipettes made from thick-
walled borosilicate glass had resistances of 0.3–0.6 MOhm when
filled with (in mM): 120 KCl, 10 HEPES, and 1.0 CaCl2, pH adjusted
to 7.2. Intracellular solution (Kint) applied via a gravity-driven multi-
barrel pipette was composed as follows (mM): 100 KCl, 10
K2EGTA, 10 HEPES (pH 7.2); intracellular solution with phospha-
tase-inhibitors (Huang et al., 1998; Woscholski et al., 1995; FVPP-
solution) contained (in mM): 55 KCl, 5 KF, 10 K4O7P2, 0.1 Na3VO4,
10 K2EGTA, 10 HEPES (pH 7.2). All substances were dissolved and
diluted to their final concentration in intracellular solution. L-a-Phos-
phatidyl-D-myo-inositol-4,5-bisphosphate (PIP2, Roche Molecular
Diagnostics or Avanti Polar Lipids), L-a-Phosphatidylinositol-3,4,5-
trisphosphate (PIP3), L-a-Phosphatidylinositol-4-monophosphate
(PIP) and L-a-Phosphatidylinositol (PI) were suspended in intracellu-
lar solution at a concentration of 1 mM, sonicated for 10 min in a cold
water bath, aliquoted, and stored at 220C. Samples were thawed
on the day of use, sonicated for another 10 min, and diluted to their
final concentration of 10 mM with intracellular solution. Two elec-
trode-voltage-clamp recordings were obtained 2–3 days after
cRNA injection. Currents were recorded with a TURBO TEC 01C am-
plifier (npi), low-pass filtered at 1 kHz, and sampled at 2 kHz using an
ITC-16 interface and Patchmaster software (HEKA). Electrodes were
filled with 3 M KCl and had resistances of 0.1–0.2 MOhm. Extracellu-
lar solution was composed as follows (mM): 100 KCl, 17.5 NaCl,
10 HEPES, and 1.8 CaCl2 (pH 7.3).
Whole-cell patch-clamp recordings on Chinese hamster ovary
(CHO) cells were done at room temperature (22C–24C) as previ-
ously described (Bildl et al., 2004; Oliver et al., 2001). Briefly, currents
were recorded with an EPC9 amplifier, filtered at 1 kHz, and sampled
at 2 kHz. Recording pipettes made from quartz glass had resis-
tances of 1–5 MOhm when filled with (in mM): 135 KCl, 2.5 MgCl2,
2.4 CaCl2, 3 NaATP, 0.1 NaGTP, 5 EGTA, and 5 HEPES (pH 7.3).
The extracellular solution contained (in mM): 144 NaCl, 5.8 KCl,
0.9 MgCl2, 1.3 CaCl2, 0.1 NaH2PO4, 5.6 D-glucose, and 10 HEPES
(pH 7.4). Wortmannin (Sigma, Germany) was dissolved in DMSO at
a stock concentration of 10 mM, stored at220C, and used at a final
concentration of 10 mM (diluted in extracellular solution).
Steady-state activation curves were determined with a tail-current
protocol. Briefly, preconditioning voltage steps (from a holding po-
tential of 0 mV) were applied to potentials between 230 mV and
2150 mV for durations ranging between 1.5 s and 5 s, before the
membrane potential was stepped to 50 mV for 500 ms to elicit
HCN tail currents. Currents recorded at the tail potential were nor-
malized to maximum, plotted versus the preconditioning potential,
and fitted with a Boltzmann function (see above). Curve fitting and
further data analysis were done with Igor Pro 4.05A on a Macintosh
G4. Data are given as mean 6 SD, unless otherwise stated.
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Murine embryonic cardiomyocytes were isolated at day E9.5 as de-
scribed (Fleischmann et al., 2004) and kept on coverslips for 2 days.
For electrophysiological recordings, the coverslips were placed into
a recording chamber and superfused with extracellular solution con-
taining (in mM): NaCl 140, KCl 5.4, MgCl2 2, CaCl2 1.8, HEPES 10, glu-
cose 10 (pH 7.4).
Patch-clamp experiments in the whole-cell configuration were
performed as detailed in Fleischmann et al. (2004). The following so-
lutions were used for electrophysiological recordings (mM). External
solution: NaCl 140, KCl 5.4, MgCl2 2, CaCl2 1.8, HEPES 10, glucose
10, BaCl2 1, 4-aminopyridine 2 (pH 7.4); internal solution: NaCl 12,
HEPES 10, MgATP 2, EGTA 10, NaGTP 0.1, K-aspartate 130 (pH 7.2).
Steady-state activation curves were determined with a tail-current
protocol as in Figure 8A; voltage was stepped for 2.5 s to potentials
between 240 mV and 2110 mV (10 mV increments) from a holding
potential of 240 mV followed by a 2.5 s voltage step to either
2110 mv or 15 mV (frequency 0.1 Hz) (Abi-Gerges et al., 2000). V1/2
and slope values were obtained from fits of a Boltzmann function
to the data as described above.
8-Br-cAMP (Sigma, Germany) stored at220C was diluted in H2O
and used at a final concentration of 100 mM; wortmannin (Sigma,
Germany) was dissolved in DMSO at a stock concentration of
10 mM, stored at 220C, and used at a final concentration of
10 mM (diluted in extracellular solution). PIP2 was handled as
described above and used at a final concentration of 20 mM in the
pipette solution. For analysis of PIP2 experiments exclusively cells
with a stable Rs < 15 MOhm were used.
Supplemental Data
The Supplemental Data for this article can be found online at http://
www.neuron.org/cgi/content/full/52/6/1027/DC1/.
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